SAMe (S-adenosylmethionine)

Harvard Review of Psychiatry

Volumn 8, Issue 2, 2000, Pages 84-90

  Echols, John C ^b   Naidoo, Umadevi ^b   Salzman, Carl ^a  

^a MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; S ADENOSYLMETHIONINE;

ANXIETY NEUROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

EID: 0033933753     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.1080/hrp_8.2.84     Document Type: Review

References (26)

1. Anonymous. SAMe for depression. Med Lett 1999;41:107.
2. Brown R, Bottiglieri T, Colman C. Stop depression now: SAM-e. New York: Putnam, 1999.
3. Di Padova CD. S-adenosylmethionine in the treatment of osteoarthritis: review of the clinical studies. Am J Med 1987; 83(suppl 5A):60-5.
4. Laudanno OM. Cytoprotective effect of S-adenosylmethionine compared with that of misoprostol against ethanol-, aspirin-, and stress-induced gastric damage. Am J Med 1987;83(suppl 5A):43-7.
5. Baldessarini RJ. Neuropharmacology of S-adenosyl-L-methionine. Am J Med 1987;83(suppl 5A):95-103.
6. Scott JM, Molloy AM, Kennedy DG, Kennedy S, Weir DG. Effects of the disruption of transmethylation in the central nervous system: an animal model. Acta Neurol Scand 1994; 89(suppl 154):27-31.
7. Abou-Saleh MT, Coppen A. The biology of folate in depression: implications for nutritional hypotheses of the psychoses. J Psychiatr Res 1986;20:91-101.
8. Bottiglieri T, Godfrey P, Flynn T, Carney MWP, Toone BK, Reynolds EH. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 1990;53:1096-8.
9. Bell KM, Potkin SG, Carreon D, Plon L. S-adenosylmethionine blood levels in major depression: changes with drug treatment. Acta Neurol Scand 1994;89(suppl 154):15-8.
10. Bottiglieri T, Laundy M, Martin R, Carney MW, Nissenbaum H, Toone BK, et al. S-adenosylmethionine influences monoamine metabolism [Letter]. Lancet 1984;2:224.
11. Giulidori P, Cortellaro M, Moreo G, Stramentinoli G. Pharmacokinetics of S-adenosyl-L-methionine in healthy volunteers. Eur J Clin Pharmacol 1984;27:119-21.
12. Agnoli A, Andreoli V, Casacchia M, Cerbo R. Effect of S-adenosyl-L-methionine (SAMe) upon depressive symptoms. J Psychiatr Res 1976;13:43-54.
13. Caruso I, Fumagalli M, Boccassini L, Puttini PS, Santandrea S, Ciniselli G, et al. Treatment of depression in rheumatoid arthritic patients. Clin Trials J 1987;24:305-10.
14. De Leo D. S-adenosylmethionine as an antidepressant: a double blind trial versus placebo. Curr Ther Res 1987;41: 865-70.
15. Salmaggi P, Bressa GM, Nicchia G, Coniglio M, La Greca P, Le Grazie C. Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women. Psychother Psychosom 1993;59:34-40.
16. Carney MWP, Edeh J, Bottiglieri T, Reynolds EH, Toone BK. Affective illness and S-adenosyl methionine: a preliminary report. Clin Neuropharmacol 1986;9:379-85.
17. Kagan BL, Sultzer DL, Rosenlicht N, Gerner RH. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 1990;147: 591-5.
18. Muscettola G, Galzenati M, Balbi A. SAMe versus placebo: a double blind comparison in major depressive disorders. In: Costa E, Racagni G, eds. Typical and atypical antidepressants: clinical practice. New York: Raven, 1982:151-6.
19. Fava M, Rosenbaum JF, Birnbaum R, Kelly K, Otto MW, MacLaughlin R. The thyrotropin response to thyrotropin-releasing hormone as a predictor of response to treatment in depressed outpatients. Acta Psychiatr Scand 1992;86:42-5.
20. Janicak PG, Lipinski J, Davis JM, Comaty JE, Waternaux C, Cohen B, et al. S-adenosylmethionine in depression: a literature review and preliminary report. Ala J Med Sci 1988;25: 306-13.
21. Bell KM, Plon L, Bunney WE Jr, Potkin SG. S-adenosylmethionine treatment of depression: a controlled clinical trial. Am J Psychiatry 1988;145:1110-4.
22. Küfferle B, Grünberger J. Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant. In: Costa E, Racagni G, ed. Typical and atypical antidepressants: clinical practice. New York: Raven, 1982:175-80.
23. Potkin SG, Bell K, Plon L, Bunney WE Jr. Rapid antidepressant response with SAMe: a double-blind study. Ala J Med Sci 1988;25:313-6.
24. Miccoli L, Porro V, Bertolino A. Comparison between the antidepressant activity of S-adenosylmethionine (SAMe) and that of some tricyclic drugs. Acta Neurol 1978;33:243-55.
25. Berlanga C, Ortega-Soto HA, Ontiveros M, Senties H. Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine. Psychiatry Res 1992;44:257-62.
26. th ed. Philadelphia: Lippincott Williams & Wilkins, 2000.